Global Yeast Infection Treatment Market is on track to exceed US$ 10,031.3 million by 2034 with a CAGR of 5.0%, as per Future Market Insights

By Future Market Insights Mar 1, 2024
Yeast Infection Treatment MarketYeast Infection Treatment Market

Future Market Insights (FMI), a leading market research firm, has released its latest industry analysis, revealing that the global yeast infection treatment market demand is poised to reach US$ 6479.8 million by 2024. The market is expected to witness a robust Compound Annual Growth Rate (CAGR) of 5.0%, projecting an estimated market size of US$ 10031.3 million by 2034.

The surge in demand for yeast infection treatment is primarily attributed to the increasing prevalence of yeast and fungal infections, notably affecting areas such as skin, hair, nails, and lungs. Future Market Insights identifies this rising demand as a key driver propelling the expansion of the global yeast infection treatment market.

Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-18675

Furthermore, the market is experiencing growth impetus from the escalating rates of illnesses such as Candidiasis and Mucormycosis. These health concerns have underscored the necessity for effective treatment solutions, contributing to the overall upward trajectory of the market. 

The broad availability of drugs for treating yeast and fungal infections and a variety of over-the-counter medications for dermal infections are the key drivers propelling the market. Players are encouraged to spend on research and development, which drives the growth of effective medications for improved results. 

Leading firms pursue several strategic activities to increase their market share, including mergers and acquisitions, regional growth, and investments. Furthermore, businesses are concentrating on getting permits for innovative items that can fill gaps in the market. 

Key Takeaways from the Market Study:

  • Azoles have led in terms of treatment type and held around 52.3% market share in 2022.
  • Based on indication, genital candidiasis is the leading segment, holding around 63.4% of the market share in 2022.
  • North America is expected to surge at a CAGR of 5.2% throughout the forecast period.
  • The global market is projected to reach a valuation of US$ 10031.3 million in 2034.
  • The yeast infection treatment market is expected to surge at a CAGR of 5.0% by 2034.

“It is projected that the yeast infection treatment market will expand due to rising rates of vaginal yeast infections worldwide. Leading players are focusing on new product launches and government approvals to expand their market presence,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Discover The Power Of Methodology-Driven Insights: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-18675

Key Companies Profiled:

  • Astellas Pharma Inc.
  • Astra Zeneca
  • Abbott Laboratories
  • Allergan
  • Brundavan Laboratories Private Limited
  • Bayer
  • Corden Pharma
  • Merck & Co., Inc.
  • Novartis
  • Pfizer Inc.
  • Synmedic Laboratories
  • Sanofi

Competitive Landscape:

Several local, new, and existing players are present in the yeast infection treatment market. Key players have started marketing campaigns to sell new drugs and topical treatments that will treat yeast infections more effectively and with fewer adverse effects.

For instance,

  • In October 2022, Intas launched Itraconazole-SB, a novel antifungal medication. This new medication will drastically save costs and improve patient compliance.
  • In May 2022, a drug called Vivjoa (oteseconazolas) received FDA approval for the treatment of both acute and chronic vaginal yeast infections.

Act Now to Explore In-Depth Market Analysis: Get Exclusive Discount Now to Access Market Reports: https://www.futuremarketinsights.com/checkout/18675


Yeast Infection Treatment Market Segmentation by Category:

By Treatment Type:

  • Azoles
  • Polygene
  • Echinocandin
  • Others

By Indication:

  • Genital Candidiasis
  • Invasive Candidiasis
  • Oropharyngeal/Esophageal Candidiasis (Thrush)
  • Others

By Route of Administration:

  • Oral
  • Topical
  • IV/IM
  • Others

By Form:

  • Powders
  • Creams/Ointments
  • Tablets/Capsules
  • Others

By Distribution Channel:

  • Retail Pharmacies/Drug Stores
  • Hospital Pharmacies
  • Specialty Stores
  • Online Sales
  • Others (Hypermarkets/ Conventional Stores)

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle-East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:

Teeth Desensitizer Market Size: The global teeth desensitizer market is expected to surge at a CAGR of 6.2% by 2034. The market value is projected to increase from US$ 147.9 million in 2024 to US$ 269.4 million in 2034.

Bone Densitometer Market Share: The bone densitometer sales worldwide are poised to register a CAGR of 2.3% from 2024 to 2034. The global bone densitometer industry is projected to account for around US$ 438.2 million in revenue by 2034, up from US$ 349.1 million in 2024.

Skincare Market Outlook: The global skincare market size is estimated to be US$ 1,66,870.4 million in 2024. The skincare product sales are expected to witness a robust CAGR of 8.6% from 2024 to 2034. By 2034, the skincare product demand is anticipated to achieve a valuation of US$ 3,80,492.2 million.

Surface Disinfectant Market Demand: The global surface disinfectant market is estimated to reach a valuation of US$ 8,095.5 million in 2024. The surface disinfectant market size is expected to surpass US$ 39,419.3 million by 2034. The worldwide sales of surface disinfectants are expected to register a CAGR of 17.2% from 2024 to 2034.

Water Testing Kit Market Growth: The global water testing kits market size is expected to surge from US$ 1.9 billion in 2024 to US$ 3.3 billion by 2034. Over the forecast period, global sales of water testing kits are anticipated to soar at a 5.4% CAGR.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani    Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
[email protected]
Website:https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Related Post